Chemoembolization, Therapeutic clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • Contrast-enhanced Ultrasound Evaluation of Chemoembolization

    open to eligible people ages 21 years and up

    The primary objective of this trial is to evaluate the sensitivity and specificity of 2D and 4D contrast enhanced ultrasound for monitoring transarterial chemoembolization (TACE) response 1-2 weeks and 1 month post treatment as an alternative to contrast-enhanced magnetic resonance (MRI) or computed tomography (CT) imaging

    La Jolla, California and other locations

Our lead scientists for Chemoembolization, Therapeutic research studies include .

Last updated: